
Two separate pens: Retatrutide 40mg + Cagrilintide 10mg
Specification
Specification for this lot is undergoing independent verification. Figures shown are provisional pending certificate of analysis.
For research and laboratory use only. Not for human consumption, diagnostic, or therapeutic use.
Retatrutide + Cagrilintide Pen Bundle · 40mg + 10mg · Certificate pending
A test certificate for Retatrutide + Cagrilintide Pen Bundle 40mg + 10mg has not been published yet. We will add it here when it is available.
A bundle containing one retatrutide 40mg pen and one cagrilintide 10mg pen, supplied separately. Retatrutide is a GIP, GLP-1 and glucagon receptor agonist; cagrilintide is an amylin analogue.
This is the two-pen bundle, separate from the 45mg blended pen. Research on the individual compounds does not establish the effects of their combined use.
These references describe the compounds. They do not certify the supplied product or batch.
No reviews yet — be the first to review Retatrutide + Cagrilintide Pen Bundle.